Viking Therapeutics (VKTX) Q3 2023 Earnings

25OctConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.26
-0.24
-0.21
-0.19

Details

Expected EPS
-0.22
Actual EPS
-0.23
Surprise EPS
-0.01
Surprise Percent
+4.55%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.23 per share for Q3 2023.

0 Comments

Share your thoughts